Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene - Wikidata - wikimedia - TriplyDB

Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene

Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene

http://www.wikidata.org/entity/Q24632288

about

Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease The APOL1 gene and allograft survival after kidney transplantation Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy APOL1 localization in normal kidney and nondiabetic kidney disease Ethnic Differences in Childhood Nephrotic Syndrome Insights into the genetic architecture of diabetic nephropathy Kidney disease: new technologies translate mechanisms to cure Hypertension and chronic kidney disease: controversies in pathogenesis and treatment Developments in renal pharmacogenomics and applications in chronic kidney disease Clinical perspectives on lupus genetics: advances and opportunities Mendelian and trans-generational inheritance in hypertensive renal disease Addressing the global burden of chronic kidney disease through clinical and translational research APOL1 and nephropathy progression in populations of African ancestry APOL1 kidney risk alleles: population genetics and disease associations The biology of APOL1 with insights into the association between APOL1 variants and chronic kidney disease Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines.The African diaspora: history, adaptation and health Population ancestry and genetic risk for diabetes and kidney, cardiovascular, and bone disease: modifiable environmental factors may produce the cures A mouse model of early-onset renal failure due to a xanthine dehydrogenase nonsense mutation Genetic variation and adaptation in Africa: implications for human evolution and disease Insights into kidney diseases from genome-wide association studies.Combined Effects of GSTM1 Null Allele and APOL1 Renal Risk Alleles in CKD Progression in the African American Study of Kidney Disease and Hypertension Trial Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans.Association Analysis of the Cubilin (CUBN) and Megalin (LRP2) Genes with ESRD in African Americans.Lack of Association of the APOL1 G3 Haplotype in African Americans with ESRD Return of results in the genomic medicine projects of the eMERGE network Effect of APOL1 disease risk variants on APOL1 gene product.Evolution of the primate trypanolytic factor APOL1 Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers.APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis.Genetic predictors of cervical dysplasia in African American HIV-infected women: ACTG DACS 268.APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.Novel susceptibility locus at 22q11 for diabetic nephropathy in type 1 diabetes.The population genetics of chronic kidney disease: insights from the MYH9-APOL1 locus.Transient expression of proteins by hydrodynamic gene delivery in mice.The New Epidemiology of HIV-Related Kidney Disease.Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury.Identification of nephropathy candidate genes by comparing sclerosis-prone and sclerosis-resistant mouse strain kidney transcriptomes.

P2860

Q21144945-D91AD722-96E8-47D0-BCE1-6667899721A4 Q24599916-8C7B37BB-024C-486B-8F9B-3285717F4A24 Q24606604-52D374F9-C757-48D0-BC99-87124F9436AB Q24621889-15587709-E0E5-4C47-A59C-3E6D266B2453 Q24631837-8615E8F8-CA5A-41D5-9B02-4ADD299F505A Q24631960-24112632-F104-4A7A-9262-F6F147BB831C Q26752347-65913BC9-F948-482E-9E10-760D4322A204 Q26823352-BF2637A2-0492-4A14-86BF-03393033AAD0 Q26825227-663EF81B-31A9-441D-ACC0-40BF5F87BA45 Q26851271-E143D2A0-BF0B-4F46-A637-6457E2B72BC3 Q26999279-673CF09B-7F6E-448D-957F-7FC439D4D24B Q27001690-2EF4C7A2-7A1A-4537-BAC5-D203BDE7B217 Q27009363-AE52E91A-4B3E-404A-8CF0-4A4F7ABE58E2 Q27014158-D96B67FA-5155-40FC-B0E2-D3E714B6B972 Q27022275-75E78307-5FF1-4F19-8467-EEC914580506 Q27024261-7EF3A643-E7F1-42A2-BB57-B7B245261461 Q27027828-44F5AECB-AADB-4009-AFB1-B4A25B4EDD3A Q27343034-C9C88BA9-3DE0-43D3-BD35-E61175A3616F Q28075805-E5DF9A74-170B-4146-8ECA-D73305915EC5 Q28391758-974384F3-28F2-4BE0-8C22-40E38911B56C Q28483790-42F90004-E5F8-4E0B-A865-78819F8EB36A Q28657760-17C02D18-5613-4286-BA20-FCCCD24864F5 Q30248678-1A6DF636-CC29-4DAC-9BA7-15372B7CDB5B Q30277219-DC02D0B9-DCD3-4C0F-BFB7-0B1907FED8FB Q30278663-7C969340-049C-4C0C-918B-5335460586B5 Q30352406-CE21F29C-555F-4CD0-98B6-27150DE0C6AE Q30359344-96D6DA02-160D-4230-942D-14C07FEEC0FA Q30575241-678DAA49-38E9-4555-88BA-5CA50CD9819D Q33613565-48795675-B15F-46F5-B871-A37A6EB41F23 Q33665446-56544E18-655A-4AF7-AE24-340AC9729550 Q33721381-F10D1BE8-5BC1-472C-9CFB-2C32E0188283 Q33866444-A699ACBD-84DA-400F-9AEB-7E2E30F1B3DA Q33988391-88C5396E-C1E0-47C9-A9A8-A8FB39F2B41C Q34001289-D789B861-859A-47C4-AD3E-EE52631049E5 Q34016561-98BA442D-9D87-4AA3-866A-31A336093FC4 Q34182007-7AC54990-150B-491A-9BB8-56C1C01A868B Q34237207-371425AD-9331-4E3F-BFA8-CFCA4A7AD7F4 Q34307868-84353266-6D15-4487-8FFC-1EAC4CDDE634 Q34336370-D6F96B01-FA1B-4E81-97B8-E2C115EABEA8 Q34343895-28CE091C-8EF0-4D02-BDA4-7F5A66E8D8CC

P2860

Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene

http://www.wikidata.org/entity/Q24632288

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Missense mutations in the APOL ...... ly attributed to the MYH9 gene

@ast

Missense mutations in the APOL ...... ly attributed to the MYH9 gene

@en

Missense mutations in the APOL ...... ly attributed to the MYH9 gene

@nl

type

label

Missense mutations in the APOL ...... ly attributed to the MYH9 gene

@ast

Missense mutations in the APOL ...... ly attributed to the MYH9 gene

@en

Missense mutations in the APOL ...... ly attributed to the MYH9 gene

@nl

prefLabel

Missense mutations in the APOL ...... ly attributed to the MYH9 gene

@ast

Missense mutations in the APOL ...... ly attributed to the MYH9 gene

@en

Missense mutations in the APOL ...... ly attributed to the MYH9 gene

@nl

P1433

Q24632288-FB69E7BA-D38D-4FB5-854E-C4E7D537A75C

P1476

Q24632288-8AC74E67-5A3F-4A31-9038-2294A1FF3F1D

P2093

Q24632288-29C6D252-FA86-4BA2-90FE-1DA2CE127D6E

Q24632288-30C74019-A9DD-4E04-839F-E9C4358DD79A

Q24632288-37E8F9C5-3ACE-481C-872F-E7FD37EE9B9F

Q24632288-5D44653D-F56F-416B-80EB-FA4633C671B6

Q24632288-842BDF0A-437F-40F4-9715-3ADB7532F2FC

Q24632288-ABB058F5-1A74-4E62-9691-2061A8BB3509

Q24632288-AC0AC482-AAFC-4723-9DCF-8EE928AFB8DB

Q24632288-C3F20FD3-4149-4AFE-8742-F907A728A4EE

Q24632288-CB71E9E9-A551-4BB0-9080-A12A1750045E

P2860

Q24632288-0DAE0A64-2F60-4CEC-BF1B-081D03D7DBA3

Q24632288-33B3562C-64E0-4D19-BAC7-86755382661A

Q24632288-34B7452C-073D-4375-94EA-4105EF17EB27

Q24632288-36976380-F207-4699-A667-BA4E6CB13D30

Q24632288-43F2ED51-9525-4E81-8DB0-C0CD8902CA96

Q24632288-469DEC0D-AC38-4F8C-BE60-DAD7A5D8A228

Q24632288-50EF7F4F-523D-4A5E-9473-1DC24E66CEDA

Q24632288-584C18C8-B9D7-4F24-B65B-B791FB5ADE33

Q24632288-720220BE-FFEB-469C-8B79-C76009EC5966

Q24632288-8E70D0A8-2AB2-4AD0-93EF-3904FE318245

P2888

Q24632288-66367818-9B4C-4302-AE26-476CD9EB6EBD

P304

Q24632288-C846A454-0A28-4CAB-9A91-9E46B415E8F8

P31

Q24632288-60028c0e-7da6-4e74-8111-1bfaf7f13fc7

Q24632288-8EA22876-6655-4B74-B849-FA4C301FD12E

P3181

Q24632288-C8BAD396-35F7-43F7-B238-007A52292B1C

P356

Q24632288-1C1FD759-A793-4431-A3B7-BEEDD375ACF7

P407

Q24632288-5EE7EB46-8A5B-4103-83BD-232EF5B84D63

P433

Q24632288-69B52E9C-CE1B-4927-A952-C2F5DD7441A2

P478

Q24632288-46846497-A2FE-44A7-A6E5-78C8AF0A1EBC

P50

Q24632288-443CB851-E5AF-45E5-939A-F9606F937498

Q24632288-F98B212D-1E10-4F4F-84FE-E22679988263

P577

Q24632288-2C262C30-6A7F-4481-A01B-524FCC3B3C58

P5875

Q24632288-8860926F-826B-4465-8C7D-34DB7D4D79DC

P6179

Q24632288-7D1724AE-528E-42FC-AA01-03B347A909F8

P698

Q24632288-43B3DE38-5A9F-4B39-8154-AC98A666D3E3

P818

Q24632288-0CB03FAE-25E2-4D16-9E1F-D2A7B3DE1F34

P932

Q24632288-8080A44D-98B6-4DC6-B21A-84ED259709D5

P3181

P356

S00439-010-0861-0

P1433

P1476

Missense mutations in the APOL ...... ly attributed to the MYH9 gene

@en

P2093

Ayele Tarekegn

http://www.w3.org/2001/XMLSchema#string

Endashaw Bekele

http://www.w3.org/2001/XMLSchema#string

Guennady Yudkovsky

http://www.w3.org/2001/XMLSchema#string

Neil Bradman

http://www.w3.org/2001/XMLSchema#string

Revital Shemer

http://www.w3.org/2001/XMLSchema#string

Saharon Rosset

http://www.w3.org/2001/XMLSchema#string

Sara Selig

http://www.w3.org/2001/XMLSchema#string

Shay Tzur

http://www.w3.org/2001/XMLSchema#string

Walter G Wasser

http://www.w3.org/2001/XMLSchema#string

P2860

C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense

The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue

Apolipoprotein L-I is the trypanosome lytic factor of human serum

Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L

Admixture dynamics in Hispanics: a shift in the nuclear genetic ancestry of a South American population isolate

African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions

Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death

MYH9 is associated with nondiabetic end-stage renal disease in African Americans

P2888

s00439-010-0861-0

P304

345-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2216437

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S00439-010-0861-0

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45200758

http://www.w3.org/2001/XMLSchema#string

P6179

1024643436

http://www.w3.org/2001/XMLSchema#string

P698

20635188

http://www.w3.org/2001/XMLSchema#string

P818

1006.4281

http://www.w3.org/2001/XMLSchema#string

P932

2921485

http://www.w3.org/2001/XMLSchema#string